nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A5—Dactinomycin—muscle cancer	0.167	0.209	CbGbCtD
Clonidine—SLC22A3—Vincristine—muscle cancer	0.166	0.208	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—muscle cancer	0.125	0.157	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—muscle cancer	0.0559	0.0701	CbGbCtD
Clonidine—ABCB1—Dactinomycin—muscle cancer	0.0424	0.0531	CbGbCtD
Clonidine—CYP3A5—Vincristine—muscle cancer	0.0401	0.0503	CbGbCtD
Clonidine—CYP3A5—Etoposide—muscle cancer	0.0368	0.0461	CbGbCtD
Clonidine—CYP1A2—Etoposide—muscle cancer	0.0274	0.0343	CbGbCtD
Clonidine—ABCB1—Vincristine—muscle cancer	0.0261	0.0327	CbGbCtD
Clonidine—ABCB1—Etoposide—muscle cancer	0.0239	0.03	CbGbCtD
Clonidine—ABCB1—Doxorubicin—muscle cancer	0.0163	0.0205	CbGbCtD
Clonidine—ABCB1—Methotrexate—muscle cancer	0.0158	0.0198	CbGbCtD
Clonidine—CYP3A4—Vincristine—muscle cancer	0.0156	0.0196	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—muscle cancer	0.0154	0.0193	CbGbCtD
Clonidine—CYP3A4—Etoposide—muscle cancer	0.0143	0.018	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—muscle cancer	0.00978	0.0123	CbGbCtD
Clonidine—SLC22A4—larynx—muscle cancer	0.00618	0.142	CbGeAlD
Clonidine—NISCH—Podofilox—Etoposide—muscle cancer	0.00414	0.592	CbGdCrCtD
Clonidine—NISCH—Vinblastine—Vincristine—muscle cancer	0.00285	0.408	CbGdCrCtD
Clonidine—NISCH—smooth muscle tissue—muscle cancer	0.00162	0.0373	CbGeAlD
Clonidine—ADRA1B—renal system—muscle cancer	0.00133	0.0306	CbGeAlD
Clonidine—SLC22A3—embryo—muscle cancer	0.00124	0.0285	CbGeAlD
Clonidine—NISCH—tendon—muscle cancer	0.00122	0.028	CbGeAlD
Clonidine—NISCH—bone marrow—muscle cancer	0.00118	0.0271	CbGeAlD
Clonidine—NISCH—vagina—muscle cancer	0.00113	0.026	CbGeAlD
Clonidine—SLC22A4—renal system—muscle cancer	0.00103	0.0237	CbGeAlD
Clonidine—NISCH—testis—muscle cancer	0.00101	0.0232	CbGeAlD
Clonidine—SLC22A1—renal system—muscle cancer	0.000984	0.0226	CbGeAlD
Clonidine—SLC22A3—smooth muscle tissue—muscle cancer	0.000977	0.0224	CbGeAlD
Clonidine—SLC22A3—renal system—muscle cancer	0.000941	0.0216	CbGeAlD
Clonidine—ADRA1B—head—muscle cancer	0.000892	0.0205	CbGeAlD
Clonidine—ADRA1D—head—muscle cancer	0.000873	0.02	CbGeAlD
Clonidine—SLC22A4—tendon—muscle cancer	0.000807	0.0185	CbGeAlD
Clonidine—SLC22A4—bone marrow—muscle cancer	0.000781	0.0179	CbGeAlD
Clonidine—ADRA1A—renal system—muscle cancer	0.000749	0.0172	CbGeAlD
Clonidine—SLC22A4—vagina—muscle cancer	0.000749	0.0172	CbGeAlD
Clonidine—ADRA2C—renal system—muscle cancer	0.000714	0.0164	CbGeAlD
Clonidine—SLC22A1—vagina—muscle cancer	0.000713	0.0164	CbGeAlD
Clonidine—SLC22A5—renal system—muscle cancer	0.000684	0.0157	CbGeAlD
Clonidine—SLC22A3—vagina—muscle cancer	0.000681	0.0156	CbGeAlD
Clonidine—SLC22A1—head—muscle cancer	0.000658	0.0151	CbGeAlD
Clonidine—ADRA2C—cardiac atrium—muscle cancer	0.000639	0.0147	CbGeAlD
Clonidine—SLC22A3—head—muscle cancer	0.000629	0.0144	CbGeAlD
Clonidine—CYP1A2—renal system—muscle cancer	0.00062	0.0142	CbGeAlD
Clonidine—SLC22A5—cardiac atrium—muscle cancer	0.000613	0.0141	CbGeAlD
Clonidine—CYP1A1—renal system—muscle cancer	0.000611	0.014	CbGeAlD
Clonidine—SLC22A3—testis—muscle cancer	0.000608	0.014	CbGeAlD
Clonidine—CYP3A5—renal system—muscle cancer	0.000598	0.0137	CbGeAlD
Clonidine—Mediastinal disorder—Vincristine—muscle cancer	0.00056	0.00369	CcSEcCtD
Clonidine—ADRA2C—tendon—muscle cancer	0.000557	0.0128	CbGeAlD
Clonidine—Alopecia—Vincristine—muscle cancer	0.000549	0.00361	CcSEcCtD
Clonidine—CYP1A1—cardiac atrium—muscle cancer	0.000547	0.0126	CbGeAlD
Clonidine—Malaise—Dactinomycin—muscle cancer	0.000546	0.00359	CcSEcCtD
Clonidine—Mental disorder—Vincristine—muscle cancer	0.000544	0.00358	CcSEcCtD
Clonidine—SLC6A2—head—muscle cancer	0.000539	0.0124	CbGeAlD
Clonidine—Gynaecomastia—Methotrexate—muscle cancer	0.000537	0.00354	CcSEcCtD
Clonidine—Atrioventricular block—Doxorubicin—muscle cancer	0.000536	0.00353	CcSEcCtD
Clonidine—SLC22A5—tendon—muscle cancer	0.000534	0.0123	CbGeAlD
Clonidine—SLC6A2—testis—muscle cancer	0.000521	0.012	CbGeAlD
Clonidine—ADRA2C—vagina—muscle cancer	0.000517	0.0119	CbGeAlD
Clonidine—Abnormal dreams—Doxorubicin—muscle cancer	0.000513	0.00338	CcSEcCtD
Clonidine—Dermatitis contact—Doxorubicin—muscle cancer	0.000513	0.00338	CcSEcCtD
Clonidine—ADRA2A—cardiac atrium—muscle cancer	0.00051	0.0117	CbGeAlD
Clonidine—Discomfort—Dactinomycin—muscle cancer	0.000509	0.00335	CcSEcCtD
Clonidine—Influenza like illness—Doxorubicin—muscle cancer	0.000505	0.00332	CcSEcCtD
Clonidine—ADRA1A—head—muscle cancer	0.000501	0.0115	CbGeAlD
Clonidine—Hypoaesthesia—Etoposide—muscle cancer	0.000501	0.0033	CcSEcCtD
Clonidine—Agitation—Vincristine—muscle cancer	0.000497	0.00327	CcSEcCtD
Clonidine—SLC22A5—vagina—muscle cancer	0.000495	0.0114	CbGeAlD
Clonidine—Oedema—Dactinomycin—muscle cancer	0.000494	0.00325	CcSEcCtD
Clonidine—Infection—Dactinomycin—muscle cancer	0.000491	0.00323	CcSEcCtD
Clonidine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000483	0.00318	CcSEcCtD
Clonidine—Dry eye—Doxorubicin—muscle cancer	0.00048	0.00316	CcSEcCtD
Clonidine—ADRA2C—head—muscle cancer	0.000478	0.011	CbGeAlD
Clonidine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000477	0.00314	CcSEcCtD
Clonidine—Rash maculo-papular—Doxorubicin—muscle cancer	0.000472	0.00311	CcSEcCtD
Clonidine—Anorexia—Dactinomycin—muscle cancer	0.000471	0.0031	CcSEcCtD
Clonidine—Eye disorder—Etoposide—muscle cancer	0.00047	0.0031	CcSEcCtD
Clonidine—Cardiac disorder—Etoposide—muscle cancer	0.000467	0.00307	CcSEcCtD
Clonidine—ADRA2C—testis—muscle cancer	0.000462	0.0106	CbGeAlD
Clonidine—Angiopathy—Etoposide—muscle cancer	0.000456	0.00301	CcSEcCtD
Clonidine—Mediastinal disorder—Etoposide—muscle cancer	0.000453	0.00299	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00045	0.00296	CcSEcCtD
Clonidine—CYP3A4—renal system—muscle cancer	0.000448	0.0103	CbGeAlD
Clonidine—ADRA2A—tendon—muscle cancer	0.000445	0.0102	CbGeAlD
Clonidine—Alopecia—Etoposide—muscle cancer	0.000445	0.00293	CcSEcCtD
Clonidine—Lethargy—Methotrexate—muscle cancer	0.000444	0.00293	CcSEcCtD
Clonidine—Cerebrovascular accident—Methotrexate—muscle cancer	0.000444	0.00293	CcSEcCtD
Clonidine—CYP1A1—vagina—muscle cancer	0.000443	0.0102	CbGeAlD
Clonidine—SLC22A5—testis—muscle cancer	0.000442	0.0101	CbGeAlD
Clonidine—CYP2D6—renal system—muscle cancer	0.000441	0.0101	CbGeAlD
Clonidine—Oedema—Vincristine—muscle cancer	0.000441	0.00291	CcSEcCtD
Clonidine—Infection—Vincristine—muscle cancer	0.000438	0.00289	CcSEcCtD
Clonidine—CYP3A5—vagina—muscle cancer	0.000433	0.00994	CbGeAlD
Clonidine—Nervous system disorder—Vincristine—muscle cancer	0.000433	0.00285	CcSEcCtD
Clonidine—Thrombocytopenia—Vincristine—muscle cancer	0.000432	0.00284	CcSEcCtD
Clonidine—Decreased appetite—Dactinomycin—muscle cancer	0.000429	0.00283	CcSEcCtD
Clonidine—Hyperhidrosis—Vincristine—muscle cancer	0.000426	0.00281	CcSEcCtD
Clonidine—Fatigue—Dactinomycin—muscle cancer	0.000426	0.0028	CcSEcCtD
Clonidine—Pain—Dactinomycin—muscle cancer	0.000422	0.00278	CcSEcCtD
Clonidine—Muscle spasms—Etoposide—muscle cancer	0.000421	0.00277	CcSEcCtD
Clonidine—Anorexia—Vincristine—muscle cancer	0.000421	0.00277	CcSEcCtD
Clonidine—ABCB1—embryo—muscle cancer	0.000419	0.00963	CbGeAlD
Clonidine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000416	0.00274	CcSEcCtD
Clonidine—Irritability—Methotrexate—muscle cancer	0.000416	0.00274	CcSEcCtD
Clonidine—ADRA2A—vagina—muscle cancer	0.000413	0.00947	CbGeAlD
Clonidine—Hypotension—Vincristine—muscle cancer	0.000412	0.00271	CcSEcCtD
Clonidine—CYP1A1—head—muscle cancer	0.000409	0.00939	CbGeAlD
Clonidine—Feeling abnormal—Dactinomycin—muscle cancer	0.000407	0.00268	CcSEcCtD
Clonidine—Ill-defined disorder—Etoposide—muscle cancer	0.000406	0.00268	CcSEcCtD
Clonidine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000404	0.00266	CcSEcCtD
Clonidine—Liver function test abnormal—Methotrexate—muscle cancer	0.000402	0.00265	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000402	0.00265	CcSEcCtD
Clonidine—Insomnia—Vincristine—muscle cancer	0.000399	0.00263	CcSEcCtD
Clonidine—Paraesthesia—Vincristine—muscle cancer	0.000396	0.00261	CcSEcCtD
Clonidine—Malaise—Etoposide—muscle cancer	0.000395	0.0026	CcSEcCtD
Clonidine—Breast disorder—Methotrexate—muscle cancer	0.000394	0.00259	CcSEcCtD
Clonidine—Abdominal pain—Dactinomycin—muscle cancer	0.00039	0.00257	CcSEcCtD
Clonidine—Body temperature increased—Dactinomycin—muscle cancer	0.00039	0.00257	CcSEcCtD
Clonidine—Loss of consciousness—Etoposide—muscle cancer	0.000385	0.00253	CcSEcCtD
Clonidine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000385	0.00253	CcSEcCtD
Clonidine—Lethargy—Doxorubicin—muscle cancer	0.000385	0.00253	CcSEcCtD
Clonidine—Decreased appetite—Vincristine—muscle cancer	0.000384	0.00253	CcSEcCtD
Clonidine—Cough—Etoposide—muscle cancer	0.000382	0.00252	CcSEcCtD
Clonidine—ADRA2A—head—muscle cancer	0.000381	0.00875	CbGeAlD
Clonidine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000381	0.00251	CcSEcCtD
Clonidine—Fatigue—Vincristine—muscle cancer	0.00038	0.0025	CcSEcCtD
Clonidine—Constipation—Vincristine—muscle cancer	0.000377	0.00248	CcSEcCtD
Clonidine—Pain—Vincristine—muscle cancer	0.000377	0.00248	CcSEcCtD
Clonidine—Pain in extremity—Doxorubicin—muscle cancer	0.000377	0.00248	CcSEcCtD
Clonidine—Asthma—Methotrexate—muscle cancer	0.000376	0.00248	CcSEcCtD
Clonidine—Chest pain—Etoposide—muscle cancer	0.000373	0.00246	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00037	0.00244	CcSEcCtD
Clonidine—Discomfort—Etoposide—muscle cancer	0.000368	0.00243	CcSEcCtD
Clonidine—ADRA2A—testis—muscle cancer	0.000368	0.00845	CbGeAlD
Clonidine—Hypersensitivity—Dactinomycin—muscle cancer	0.000364	0.0024	CcSEcCtD
Clonidine—Gastrointestinal pain—Vincristine—muscle cancer	0.000361	0.00238	CcSEcCtD
Clonidine—Confusional state—Etoposide—muscle cancer	0.00036	0.00237	CcSEcCtD
Clonidine—Infection—Etoposide—muscle cancer	0.000355	0.00234	CcSEcCtD
Clonidine—Asthenia—Dactinomycin—muscle cancer	0.000354	0.00233	CcSEcCtD
Clonidine—Dysuria—Methotrexate—muscle cancer	0.000352	0.00232	CcSEcCtD
Clonidine—Thrombocytopenia—Etoposide—muscle cancer	0.00035	0.0023	CcSEcCtD
Clonidine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00035	0.0023	CcSEcCtD
Clonidine—Tachycardia—Etoposide—muscle cancer	0.000349	0.0023	CcSEcCtD
Clonidine—Abdominal pain—Vincristine—muscle cancer	0.000349	0.0023	CcSEcCtD
Clonidine—Body temperature increased—Vincristine—muscle cancer	0.000349	0.0023	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000348	0.00229	CcSEcCtD
Clonidine—Skin disorder—Etoposide—muscle cancer	0.000347	0.00229	CcSEcCtD
Clonidine—Erectile dysfunction—Methotrexate—muscle cancer	0.000347	0.00228	CcSEcCtD
Clonidine—Hyperhidrosis—Etoposide—muscle cancer	0.000345	0.00228	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000344	0.00227	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000344	0.00227	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—muscle cancer	0.000341	0.00224	CcSEcCtD
Clonidine—Anorexia—Etoposide—muscle cancer	0.000341	0.00224	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—muscle cancer	0.000338	0.00222	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000337	0.00222	CcSEcCtD
Clonidine—Drowsiness—Methotrexate—muscle cancer	0.000336	0.00221	CcSEcCtD
Clonidine—Depression—Methotrexate—muscle cancer	0.000335	0.0022	CcSEcCtD
Clonidine—Hypotension—Etoposide—muscle cancer	0.000334	0.0022	CcSEcCtD
Clonidine—Asthma—Doxorubicin—muscle cancer	0.000326	0.00215	CcSEcCtD
Clonidine—Hypersensitivity—Vincristine—muscle cancer	0.000325	0.00214	CcSEcCtD
Clonidine—Sweating—Methotrexate—muscle cancer	0.000322	0.00212	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—muscle cancer	0.000321	0.00211	CcSEcCtD
Clonidine—Dyspnoea—Etoposide—muscle cancer	0.000319	0.0021	CcSEcCtD
Clonidine—Somnolence—Etoposide—muscle cancer	0.000318	0.00209	CcSEcCtD
Clonidine—ABCB1—renal system—muscle cancer	0.000317	0.00729	CbGeAlD
Clonidine—Epistaxis—Methotrexate—muscle cancer	0.000317	0.00208	CcSEcCtD
Clonidine—Asthenia—Vincristine—muscle cancer	0.000317	0.00208	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—muscle cancer	0.000314	0.00207	CcSEcCtD
Clonidine—Rash—Dactinomycin—muscle cancer	0.000311	0.00205	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—muscle cancer	0.000311	0.00205	CcSEcCtD
Clonidine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000309	0.00203	CcSEcCtD
Clonidine—Fatigue—Etoposide—muscle cancer	0.000308	0.00203	CcSEcCtD
Clonidine—Pain—Etoposide—muscle cancer	0.000306	0.00201	CcSEcCtD
Clonidine—Constipation—Etoposide—muscle cancer	0.000306	0.00201	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—muscle cancer	0.000305	0.00201	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000303	0.002	CcSEcCtD
Clonidine—Diarrhoea—Vincristine—muscle cancer	0.000302	0.00199	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—muscle cancer	0.000301	0.00198	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—muscle cancer	0.000301	0.00198	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—muscle cancer	0.000297	0.00195	CcSEcCtD
Clonidine—CYP2D6—head—muscle cancer	0.000295	0.00678	CbGeAlD
Clonidine—Feeling abnormal—Etoposide—muscle cancer	0.000295	0.00194	CcSEcCtD
Clonidine—Nausea—Dactinomycin—muscle cancer	0.000293	0.00193	CcSEcCtD
Clonidine—Gastrointestinal pain—Etoposide—muscle cancer	0.000292	0.00192	CcSEcCtD
Clonidine—Dizziness—Vincristine—muscle cancer	0.000292	0.00192	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—muscle cancer	0.000291	0.00191	CcSEcCtD
Clonidine—CYP2D6—testis—muscle cancer	0.000285	0.00655	CbGeAlD
Clonidine—Urticaria—Etoposide—muscle cancer	0.000284	0.00187	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—muscle cancer	0.000283	0.00186	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—muscle cancer	0.000283	0.00186	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—muscle cancer	0.000283	0.00186	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—muscle cancer	0.000282	0.00185	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—muscle cancer	0.000281	0.00185	CcSEcCtD
Clonidine—Vomiting—Vincristine—muscle cancer	0.000281	0.00185	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—muscle cancer	0.00028	0.00184	CcSEcCtD
Clonidine—Sweating—Doxorubicin—muscle cancer	0.000279	0.00183	CcSEcCtD
Clonidine—Rash—Vincristine—muscle cancer	0.000278	0.00183	CcSEcCtD
Clonidine—Dermatitis—Vincristine—muscle cancer	0.000278	0.00183	CcSEcCtD
Clonidine—Headache—Vincristine—muscle cancer	0.000276	0.00182	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—muscle cancer	0.000274	0.00181	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—muscle cancer	0.000273	0.0018	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—muscle cancer	0.000272	0.00179	CcSEcCtD
Clonidine—Alopecia—Methotrexate—muscle cancer	0.000266	0.00175	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—muscle cancer	0.000266	0.00175	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—muscle cancer	0.000264	0.00174	CcSEcCtD
Clonidine—Hypersensitivity—Etoposide—muscle cancer	0.000263	0.00173	CcSEcCtD
Clonidine—Erythema—Methotrexate—muscle cancer	0.000262	0.00173	CcSEcCtD
Clonidine—Nausea—Vincristine—muscle cancer	0.000262	0.00173	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—muscle cancer	0.000262	0.00172	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—muscle cancer	0.000261	0.00172	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00026	0.00171	CcSEcCtD
Clonidine—Asthenia—Etoposide—muscle cancer	0.000256	0.00169	CcSEcCtD
Clonidine—Pruritus—Etoposide—muscle cancer	0.000253	0.00167	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—muscle cancer	0.000247	0.00163	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—muscle cancer	0.000245	0.00161	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—muscle cancer	0.000244	0.00161	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—muscle cancer	0.000243	0.0016	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—muscle cancer	0.000243	0.0016	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—muscle cancer	0.000242	0.00159	CcSEcCtD
Clonidine—ABCB1—bone marrow—muscle cancer	0.00024	0.00551	CbGeAlD
Clonidine—Angiopathy—Doxorubicin—muscle cancer	0.000237	0.00156	CcSEcCtD
Clonidine—Malaise—Methotrexate—muscle cancer	0.000237	0.00156	CcSEcCtD
Clonidine—Dizziness—Etoposide—muscle cancer	0.000236	0.00156	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000235	0.00155	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—muscle cancer	0.000233	0.00153	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—muscle cancer	0.000231	0.00152	CcSEcCtD
Clonidine—ABCB1—vagina—muscle cancer	0.00023	0.00528	CbGeAlD
Clonidine—Cough—Methotrexate—muscle cancer	0.000229	0.00151	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—muscle cancer	0.000229	0.00151	CcSEcCtD
Clonidine—Vomiting—Etoposide—muscle cancer	0.000227	0.0015	CcSEcCtD
Clonidine—Erythema—Doxorubicin—muscle cancer	0.000227	0.0015	CcSEcCtD
Clonidine—Rash—Etoposide—muscle cancer	0.000225	0.00148	CcSEcCtD
Clonidine—Dermatitis—Etoposide—muscle cancer	0.000225	0.00148	CcSEcCtD
Clonidine—Headache—Etoposide—muscle cancer	0.000224	0.00147	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—muscle cancer	0.000223	0.00147	CcSEcCtD
Clonidine—Chest pain—Methotrexate—muscle cancer	0.000223	0.00147	CcSEcCtD
Clonidine—Tension—Doxorubicin—muscle cancer	0.000223	0.00147	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000222	0.00146	CcSEcCtD
Clonidine—Discomfort—Methotrexate—muscle cancer	0.000221	0.00145	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—muscle cancer	0.000221	0.00145	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—muscle cancer	0.000218	0.00144	CcSEcCtD
Clonidine—Confusional state—Methotrexate—muscle cancer	0.000216	0.00142	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—muscle cancer	0.000214	0.00141	CcSEcCtD
Clonidine—Infection—Methotrexate—muscle cancer	0.000213	0.0014	CcSEcCtD
Clonidine—ABCB1—head—muscle cancer	0.000212	0.00488	CbGeAlD
Clonidine—Nausea—Etoposide—muscle cancer	0.000212	0.0014	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000211	0.00139	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—muscle cancer	0.00021	0.00138	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—muscle cancer	0.00021	0.00138	CcSEcCtD
Clonidine—Agitation—Doxorubicin—muscle cancer	0.000209	0.00137	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—muscle cancer	0.000208	0.00137	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—muscle cancer	0.000207	0.00136	CcSEcCtD
Clonidine—ABCB1—testis—muscle cancer	0.000205	0.00471	CbGeAlD
Clonidine—Malaise—Doxorubicin—muscle cancer	0.000205	0.00135	CcSEcCtD
Clonidine—Anorexia—Methotrexate—muscle cancer	0.000204	0.00134	CcSEcCtD
Clonidine—Syncope—Doxorubicin—muscle cancer	0.000204	0.00134	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—muscle cancer	0.000201	0.00132	CcSEcCtD
Clonidine—Hypotension—Methotrexate—muscle cancer	0.0002	0.00132	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—muscle cancer	0.0002	0.00131	CcSEcCtD
Clonidine—Cough—Doxorubicin—muscle cancer	0.000198	0.00131	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000195	0.00128	CcSEcCtD
Clonidine—Insomnia—Methotrexate—muscle cancer	0.000194	0.00128	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—muscle cancer	0.000193	0.00127	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—muscle cancer	0.000193	0.00127	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—muscle cancer	0.000193	0.00127	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—muscle cancer	0.000192	0.00127	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000192	0.00126	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—muscle cancer	0.000191	0.00126	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—muscle cancer	0.000191	0.00126	CcSEcCtD
Clonidine—Somnolence—Methotrexate—muscle cancer	0.00019	0.00125	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—muscle cancer	0.000189	0.00125	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—muscle cancer	0.000187	0.00123	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—muscle cancer	0.000186	0.00123	CcSEcCtD
Clonidine—Oedema—Doxorubicin—muscle cancer	0.000185	0.00122	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000185	0.00122	CcSEcCtD
Clonidine—Fatigue—Methotrexate—muscle cancer	0.000185	0.00122	CcSEcCtD
Clonidine—Infection—Doxorubicin—muscle cancer	0.000184	0.00121	CcSEcCtD
Clonidine—Pain—Methotrexate—muscle cancer	0.000183	0.00121	CcSEcCtD
Clonidine—Shock—Doxorubicin—muscle cancer	0.000182	0.0012	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—muscle cancer	0.000182	0.0012	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000181	0.0012	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—muscle cancer	0.000181	0.00119	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—muscle cancer	0.00018	0.00119	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000179	0.00118	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—muscle cancer	0.000177	0.00116	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—muscle cancer	0.000176	0.00116	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000175	0.00115	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—muscle cancer	0.000173	0.00114	CcSEcCtD
Clonidine—Urticaria—Methotrexate—muscle cancer	0.00017	0.00112	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—muscle cancer	0.000169	0.00111	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—muscle cancer	0.000169	0.00111	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000169	0.00111	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—muscle cancer	0.000168	0.0011	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—muscle cancer	0.000166	0.0011	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—muscle cancer	0.000165	0.00109	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—muscle cancer	0.000165	0.00109	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—muscle cancer	0.000161	0.00106	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00016	0.00105	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—muscle cancer	0.00016	0.00105	CcSEcCtD
Clonidine—Pain—Doxorubicin—muscle cancer	0.000159	0.00104	CcSEcCtD
Clonidine—Constipation—Doxorubicin—muscle cancer	0.000159	0.00104	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—muscle cancer	0.000158	0.00104	CcSEcCtD
Clonidine—Asthenia—Methotrexate—muscle cancer	0.000154	0.00101	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—muscle cancer	0.000153	0.00101	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000152	0.000998	CcSEcCtD
Clonidine—Pruritus—Methotrexate—muscle cancer	0.000151	0.000997	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—muscle cancer	0.000147	0.00097	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—muscle cancer	0.000147	0.000965	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—muscle cancer	0.000147	0.000965	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—muscle cancer	0.000146	0.000965	CcSEcCtD
Clonidine—Dizziness—Methotrexate—muscle cancer	0.000142	0.000932	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—muscle cancer	0.000137	0.000899	CcSEcCtD
Clonidine—Vomiting—Methotrexate—muscle cancer	0.000136	0.000896	CcSEcCtD
Clonidine—Rash—Methotrexate—muscle cancer	0.000135	0.000889	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—muscle cancer	0.000135	0.000888	CcSEcCtD
Clonidine—Headache—Methotrexate—muscle cancer	0.000134	0.000883	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—muscle cancer	0.000133	0.000876	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—muscle cancer	0.000131	0.000864	CcSEcCtD
Clonidine—Nausea—Methotrexate—muscle cancer	0.000127	0.000837	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—muscle cancer	0.000127	0.000835	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—muscle cancer	0.000123	0.000807	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—muscle cancer	0.000118	0.000776	CcSEcCtD
Clonidine—Rash—Doxorubicin—muscle cancer	0.000117	0.00077	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—muscle cancer	0.000117	0.000769	CcSEcCtD
Clonidine—Headache—Doxorubicin—muscle cancer	0.000116	0.000765	CcSEcCtD
Clonidine—Nausea—Doxorubicin—muscle cancer	0.00011	0.000725	CcSEcCtD
